DV Biomed Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	100.11	113.96	213.98	226.25	456.83	557.62
Short-Term Investments	182	81.87	100.54	45.22	124	38.5
Trading Asset Securities	70.46	125.96	65.91	4.38	4.34	4.74
Cash & Short-Term Investments	352.56	321.79	380.42	275.85	585.17	600.86
Cash Growth	11.13%	-15.41%	37.91%	-52.86%	-2.61%	11.62%
Accounts Receivable	35	29.53	55.05	80.19	239.56	292.18
Other Receivables	10.05	10.1	7	5.88	17	14.3
Receivables	45.05	39.63	62.06	86.07	256.55	306.49
Inventory	136.72	113.67	74.84	66.73	133.9	132.07
Prepaid Expenses	3.8	7.92	38.96	15.36	30.09	38.47
Other Current Assets	6.04	6.09	0.22	0.57	0.06	-
Total Current Assets	544.17	489.09	556.5	444.57	1,006	1,078
Property, Plant & Equipment	62.78	72.8	47.53	55.31	585.81	415.6
Long-Term Investments	36.8	36.8	30.04	-	182.43	178.23
Other Intangible Assets	1.99	2.38	4.12	0.9	3.43	5.32
Long-Term Accounts Receivable	-	-	67.51	-	-	-
Long-Term Deferred Tax Assets	66.44	66.33	65.57	66.22	77.03	64.33
Other Long-Term Assets	8.01	9.78	5.94	28.29	198.78	116.22
Total Assets	720.18	677.18	777.22	595.29	2,053	1,858

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	32.84	36.26	32.85	28	110.25	115.37
Accrued Expenses	31.64	47.12	41.27	68.78	81.54	83.78
Current Portion of Leases	14.86	15.56	32.11	3.75	80.66	62.32
Current Income Taxes Payable	11.67	-	4.7	-	41.52	43.05
Current Unearned Revenue	21.86	10.75	3.29	1.28	116.21	115.27
Other Current Liabilities	31.68	28.05	24.4	13.05	50.58	69.28
Total Current Liabilities	144.56	137.74	138.62	114.87	480.77	489.07
Long-Term Leases	21.79	29.95	99.63	-	385.86	161.77
Long-Term Deferred Tax Liabilities	0.43	0.04	0.94	0.12	6.92	-
Other Long-Term Liabilities	3.8	2.08	3.82	3.82	34.6	27.85
Total Liabilities	170.58	169.81	243.01	118.81	908.14	678.68

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	243.49	243.49	208.61	604.47	614.47	602.61
Additional Paid-In Capital	7.03	7.03	7.11	190.28	211.51	179.37
Retained Earnings	309.82	266.98	345.74	307.27	431.35	468.6
Treasury Stock	-	-	-14.55	-42.16	-100.69	-58.53
Comprehensive Income & Other	-10.73	-10.13	-12.7	-13.09	-11.53	-13.16
Total Common Equity	549.61	507.37	534.21	1,047	1,145	1,179
Minority Interest	-	-	-	-570.29	-	-
Shareholders' Equity	549.61	507.37	534.21	476.48	1,145	1,179
Total Liabilities & Equity	720.18	677.18	777.22	595.29	2,053	1,858

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	36.65	45.51	131.74	3.75	466.52	224.09
Net Cash (Debt)	315.91	276.28	248.69	272.1	118.65	376.77
Net Cash Growth	17.35%	11.09%	-8.60%	129.34%	-68.51%	30.65%
Net Cash Per Share	12.97	11.34	10.20	11.14	4.85	15.29
Filing Date Shares Outstanding	24.35	24.35	24.35	24.35	24.35	24.62
Total Common Shares Outstanding	24.35	24.35	24.35	24.35	24.35	24.62
Working Capital	399.61	351.35	417.88	329.7	525.01	588.81
Book Value Per Share	22.57	20.84	21.94	42.99	47.03	47.88
Tangible Book Value	547.62	504.99	530.08	1,046	1,142	1,174
Tangible Book Value Per Share	22.49	20.74	21.77	42.95	46.89	47.66
Buildings	-	-	-	55.62	81.98	80.66
Machinery	28.48	28.4	17.83	17.75	332.79	75.96
Construction In Progress	-	12.43	-	-	23	15.29
Leasehold Improvements	18.29	4.47	22.52	21.6	-	225.83